Neuronetics STIM
NASDAQ STIM
$3.08 -0.06 (-1.76%)
At close: Aug 20, 2026 · 1:27 PM UTC

Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026)

Neuronetics (STIM) posted quarterly Income from Non-Controlling Interests of $10000.0 for Q1 2026, up 171.43% year-over-year from $3684.2 in Q1 2025, and up 120.83% quarter-over-quarter from -$48000.0 in Q4 2025.

Neuronetics (STIM) Income from Non-Controlling Interests (2025 - 2026) Analysis & Trends

Neuronetics (STIM) has reported Income from Non-Controlling Interests for 2 consecutive years, with $10000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Income from Non-Controlling Interests rose 171.43% year-over-year to $10000.0; the TTM figure through Mar 2026 stood at -$113000.0 (changed N/A YoY), while the FY2025 annual figure was -$137000.0, down 621.05% from the prior year.
  • Income from Non-Controlling Interests climbed to $10000.0 in Q1 2026 per STIM's latest filing, from -$48000.0 in the prior quarter.
  • Across five years, Income from Non-Controlling Interests topped out at $281000.0 in Q2 2025 and bottomed at -$356000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Inc. Minority (Qtr)
1 Abbott Laboratories 198.81 Bn 193.21 Bn 7.27 Bn -
2 Stryker 127.76 Bn 124.28 Bn 4.50 Bn -
3 Medtronic 118.77 Bn 109.55 Bn 6.41 Bn 16.00 Mn
4 Boston Scientific 73.25 Bn 72.71 Bn 3.85 Bn -2.00 Mn
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -500,000.00
6 Dexcom 34.43 Bn 32.49 Bn 830.00 Mn -
7 GE HealthCare Technologies 33.88 Bn 31.77 Bn 2.18 Bn 13.00 Mn
8 Koninklijke Philips 26.35 Bn 23.03 Bn 4.55 Bn 2.32 Mn
9 Steris 23.11 Bn 22.63 Bn 684.20 Mn 900,000.00
10 Neuronetics 225.57 Mn 206.14 Mn 21.22 Mn -25,000.00

Historic Data

Download Data
DateValue
Jun 30, 2026 -25,000.00
Mar 31, 2026 10,000.00
Dec 31, 2025 -48,000.00
Sep 30, 2025 -356,000.00
Jun 30, 2025 281,000.00
Mar 31, 2025 -14,000.00